Peroxisome proliferator-activated receptors modulate cardiac dysfunction in diabetic cardiomyopathy

T. I. Lee, Y. H. Kao, Y. C. Chen, J. H. Huang, F. C. Hsiao, Y. J. Chen

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

Cardiovascular disease (CVD) is the leading cause of morbidity and mortality among patients with diabetes mellitus (DM). Chronic inflammation and derangement of myocardial energy and lipid homeostasis are common features of DM. The transcription factors of peroxisome proliferator-activated receptors (PPARs) belong to the nuclear receptor superfamily, which are important in regulating energy and lipid homeostasis. There are three PPAR isoforms, α, γ, and δ, and their roles have been increasingly recognized to be important in CVD. These three isoforms are expressed in the heart and play pivotal roles in myocardial lipid metabolism, as well as glucose and energy homeostasis, and contribute to extra metabolic roles with effects on inflammation and oxidative stress. Moreover, regulation of PPARs may have significant effects on cardiac electrical activity and arrhythmogenesis. This review describes the roles of PPARs and their agonists in DM cardiomyopathy, inflammation, and cardiac electrophysiology.

Original languageEnglish
Pages (from-to)330-339
Number of pages10
JournalDiabetes Research and Clinical Practice
Volume100
Issue number3
DOIs
Publication statusPublished - Jun 2013

Fingerprint

Diabetic Cardiomyopathies
Peroxisome Proliferator-Activated Receptors
Diabetes Mellitus
Homeostasis
Inflammation
Protein Isoforms
Cardiovascular Diseases
Cardiac Electrophysiology
Lipids
Cytoplasmic and Nuclear Receptors
Cardiomyopathies
Lipid Metabolism
Oxidative Stress
Transcription Factors
Morbidity
Glucose
Mortality

Keywords

  • Cardiomyocytes
  • Diabetes mellitus
  • Hypertension
  • Peroxisome proliferator-activated receptors

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Internal Medicine
  • Endocrinology

Cite this

Peroxisome proliferator-activated receptors modulate cardiac dysfunction in diabetic cardiomyopathy. / Lee, T. I.; Kao, Y. H.; Chen, Y. C.; Huang, J. H.; Hsiao, F. C.; Chen, Y. J.

In: Diabetes Research and Clinical Practice, Vol. 100, No. 3, 06.2013, p. 330-339.

Research output: Contribution to journalArticle

@article{be330aca12e74007b4df4fa340954039,
title = "Peroxisome proliferator-activated receptors modulate cardiac dysfunction in diabetic cardiomyopathy",
abstract = "Cardiovascular disease (CVD) is the leading cause of morbidity and mortality among patients with diabetes mellitus (DM). Chronic inflammation and derangement of myocardial energy and lipid homeostasis are common features of DM. The transcription factors of peroxisome proliferator-activated receptors (PPARs) belong to the nuclear receptor superfamily, which are important in regulating energy and lipid homeostasis. There are three PPAR isoforms, α, γ, and δ, and their roles have been increasingly recognized to be important in CVD. These three isoforms are expressed in the heart and play pivotal roles in myocardial lipid metabolism, as well as glucose and energy homeostasis, and contribute to extra metabolic roles with effects on inflammation and oxidative stress. Moreover, regulation of PPARs may have significant effects on cardiac electrical activity and arrhythmogenesis. This review describes the roles of PPARs and their agonists in DM cardiomyopathy, inflammation, and cardiac electrophysiology.",
keywords = "Cardiomyocytes, Diabetes mellitus, Hypertension, Peroxisome proliferator-activated receptors",
author = "Lee, {T. I.} and Kao, {Y. H.} and Chen, {Y. C.} and Huang, {J. H.} and Hsiao, {F. C.} and Chen, {Y. J.}",
year = "2013",
month = "6",
doi = "10.1016/j.diabres.2013.01.008",
language = "English",
volume = "100",
pages = "330--339",
journal = "Diabetes Research and Clinical Practice",
issn = "0168-8227",
publisher = "Elsevier Ireland Ltd",
number = "3",

}

TY - JOUR

T1 - Peroxisome proliferator-activated receptors modulate cardiac dysfunction in diabetic cardiomyopathy

AU - Lee, T. I.

AU - Kao, Y. H.

AU - Chen, Y. C.

AU - Huang, J. H.

AU - Hsiao, F. C.

AU - Chen, Y. J.

PY - 2013/6

Y1 - 2013/6

N2 - Cardiovascular disease (CVD) is the leading cause of morbidity and mortality among patients with diabetes mellitus (DM). Chronic inflammation and derangement of myocardial energy and lipid homeostasis are common features of DM. The transcription factors of peroxisome proliferator-activated receptors (PPARs) belong to the nuclear receptor superfamily, which are important in regulating energy and lipid homeostasis. There are three PPAR isoforms, α, γ, and δ, and their roles have been increasingly recognized to be important in CVD. These three isoforms are expressed in the heart and play pivotal roles in myocardial lipid metabolism, as well as glucose and energy homeostasis, and contribute to extra metabolic roles with effects on inflammation and oxidative stress. Moreover, regulation of PPARs may have significant effects on cardiac electrical activity and arrhythmogenesis. This review describes the roles of PPARs and their agonists in DM cardiomyopathy, inflammation, and cardiac electrophysiology.

AB - Cardiovascular disease (CVD) is the leading cause of morbidity and mortality among patients with diabetes mellitus (DM). Chronic inflammation and derangement of myocardial energy and lipid homeostasis are common features of DM. The transcription factors of peroxisome proliferator-activated receptors (PPARs) belong to the nuclear receptor superfamily, which are important in regulating energy and lipid homeostasis. There are three PPAR isoforms, α, γ, and δ, and their roles have been increasingly recognized to be important in CVD. These three isoforms are expressed in the heart and play pivotal roles in myocardial lipid metabolism, as well as glucose and energy homeostasis, and contribute to extra metabolic roles with effects on inflammation and oxidative stress. Moreover, regulation of PPARs may have significant effects on cardiac electrical activity and arrhythmogenesis. This review describes the roles of PPARs and their agonists in DM cardiomyopathy, inflammation, and cardiac electrophysiology.

KW - Cardiomyocytes

KW - Diabetes mellitus

KW - Hypertension

KW - Peroxisome proliferator-activated receptors

UR - http://www.scopus.com/inward/record.url?scp=84878493642&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84878493642&partnerID=8YFLogxK

U2 - 10.1016/j.diabres.2013.01.008

DO - 10.1016/j.diabres.2013.01.008

M3 - Article

C2 - 23369225

AN - SCOPUS:84878493642

VL - 100

SP - 330

EP - 339

JO - Diabetes Research and Clinical Practice

JF - Diabetes Research and Clinical Practice

SN - 0168-8227

IS - 3

ER -